New malaria vaccine that cuts cases in half in trial could save millions of African childrenDrug maker GlaxoSmithKline (GSK) said on Tuesday it hoped to get the green light for a prototype vaccine against malaria after trials showed it offered children a partial shield against the disease. Oct 08, 2013
